Hui Y Yu from 24658 SE 36Th Ct, Bellevue, WA 98029, age 58, Phone: (425)8900436

Medicine Doctors

Hui Ying Yu

view source

Specialties:

Neurology, Neuromuscular Medicine

Work:

Winthrop Univ Hosp NeurologyWinthrop Neurosience Medical PC
200 Old Country Rd STE 370, Mineola, NY 11501
(516)6634525 (phone), (516)6634532 (fax)

Education:

Medical School
Bethune Med Univ, Changchun City, Jilin, China
Graduated: 1986

Procedures:

Neurological Testing
Sleep and EEG Testing

Conditions:

Carpel Tunnel Syndrome
Epilepsy
Ischemic Stroke
Migraine Headache
Multiple Sclerosis (MS)

Languages:

Chinese
English
Polish

Description:

Dr. Yu graduated from the Bethune Med Univ, Changchun City, Jilin, China in 1986. She works in Mineola, NY and specializes in Neurology and Neuromuscular Medicine. Dr. Yu is affiliated with Winthrop University Hospital.

Hui Yu

view source

Specialties:

Anatomic Pathology & Clinical Pathology

Name / Title

Company / Classification

Phones & Addresses

Hui Ren Yu
President

HAPPY FAMILY INCORPORATED

258 Salem Rd, Billerica, MA 01821
474 Tremont St #66, Boston, MA

Hui Yu
Treasurer

MING WING INTERNATIONAL, INC

1640 Worcester Rd, Framingham, MA 01701

Hui Yu
President

USA MESON FERTILIZER (YANTAI) INC

Us Patents

Co-Use Of Lenalidomide With Car-T Cells
view source
US Patent:

20220193134, Jun 23, 2022
Filed:

Dec 22, 2021
Appl. No.:

17/559355
Inventors:

- Zug, CH
Jason SAGERT - Cambridge MA, US
Jonathan Alexander TERRETT - Cambridge MA, US
Hui YU - Cambridge MA, US
International Classification:

A61K 35/17
C12N 5/0783
A61K 31/454
C07K 16/28
A61P 35/00
C07K 14/705
C07K 14/725
Abstract:

A method for producing T cells expressing a chimeric antigen receptor (CAR-T cells), comprising: (i) culturing CAR-T cells in a medium comprising lenalidomide or a derivative thereof to produce CAR-T cells, and optionally (ii) administering the CAR-T cells to a subject in need of the treatment.

Methods Of Manufacturing Car-T Cells
view source
US Patent:

20210139935, May 13, 2021
Filed:

Nov 13, 2020
Appl. No.:

17/098219
Inventors:

- Zug, CH
Demetrios Kalaitzidis - Cambridge MA, US
Siyuan Tan - Cambridge MA, US
Hui Yu - Cambridge MA, US
International Classification:

C12N 15/90
C12N 15/11
C12N 9/22
C12N 5/0783
Abstract:

Aspects of the present disclosure relate to methods for manufacturing genetically engineered T cells expressing a chimeric antigen receptor (CAR) that provide several improvements over conventional manufacturing methods, thereby enabling production of a robust supply of clinically useful CAR T-cell therapies.